Cargando…

Systematically Analyzing the Pathogenic Variations for Acute Intermittent Porphyria

The rare autosomal dominant disorder acute intermittent porphyria (AIP) is caused by the deficient activity of hydroxymethylbilane synthase (HMBS). The symptoms of AIP are acute neurovisceral attacks which are induced by the dysfunction of heme biosynthesis. To better interpret the underlying mechan...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Yibao, Jia, Jinmeng, Yue, Lishu, Yang, Ruiying, Guo, Yongli, Ni, Xin, Shi, Tieliu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753391/
https://www.ncbi.nlm.nih.gov/pubmed/31572191
http://dx.doi.org/10.3389/fphar.2019.01018
_version_ 1783452892388130816
author Fu, Yibao
Jia, Jinmeng
Yue, Lishu
Yang, Ruiying
Guo, Yongli
Ni, Xin
Shi, Tieliu
author_facet Fu, Yibao
Jia, Jinmeng
Yue, Lishu
Yang, Ruiying
Guo, Yongli
Ni, Xin
Shi, Tieliu
author_sort Fu, Yibao
collection PubMed
description The rare autosomal dominant disorder acute intermittent porphyria (AIP) is caused by the deficient activity of hydroxymethylbilane synthase (HMBS). The symptoms of AIP are acute neurovisceral attacks which are induced by the dysfunction of heme biosynthesis. To better interpret the underlying mechanism of clinical phenotypes, we collected 117 HMBS gene mutations from reported individuals with AIP and evaluated the mutations’ impacts on the corresponding protein structure and function. We found that several mutations with most severe clinical symptoms are located at dipyromethane cofactor (DPM) binding domain of HMBS. Mutations on these residues likely significantly influence the catalytic reaction. To infer new pathogenic mutations, we evaluated the pathogenicity for all the possible missense mutations of HMBS gene with different bioinformatic prediction algorithms, and identified 34 mutations with serious pathogenicity and low allele frequency. In addition, we found that gene PPARA may also play an important role in the mechanisms of AIP attacks. Our analysis about the distribution frequencies of the 23 variations revealed different distribution patterns among eight ethnic populations, which could help to explain the genetic basis that may contribute to population disparities in AIP prevalence. Our systematic analysis provides a better understanding for this disease and helps for the diagnosis and treatment of AIP.
format Online
Article
Text
id pubmed-6753391
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-67533912019-09-30 Systematically Analyzing the Pathogenic Variations for Acute Intermittent Porphyria Fu, Yibao Jia, Jinmeng Yue, Lishu Yang, Ruiying Guo, Yongli Ni, Xin Shi, Tieliu Front Pharmacol Pharmacology The rare autosomal dominant disorder acute intermittent porphyria (AIP) is caused by the deficient activity of hydroxymethylbilane synthase (HMBS). The symptoms of AIP are acute neurovisceral attacks which are induced by the dysfunction of heme biosynthesis. To better interpret the underlying mechanism of clinical phenotypes, we collected 117 HMBS gene mutations from reported individuals with AIP and evaluated the mutations’ impacts on the corresponding protein structure and function. We found that several mutations with most severe clinical symptoms are located at dipyromethane cofactor (DPM) binding domain of HMBS. Mutations on these residues likely significantly influence the catalytic reaction. To infer new pathogenic mutations, we evaluated the pathogenicity for all the possible missense mutations of HMBS gene with different bioinformatic prediction algorithms, and identified 34 mutations with serious pathogenicity and low allele frequency. In addition, we found that gene PPARA may also play an important role in the mechanisms of AIP attacks. Our analysis about the distribution frequencies of the 23 variations revealed different distribution patterns among eight ethnic populations, which could help to explain the genetic basis that may contribute to population disparities in AIP prevalence. Our systematic analysis provides a better understanding for this disease and helps for the diagnosis and treatment of AIP. Frontiers Media S.A. 2019-09-13 /pmc/articles/PMC6753391/ /pubmed/31572191 http://dx.doi.org/10.3389/fphar.2019.01018 Text en Copyright © 2019 Fu, Jia, Yue, Yang, Guo, Ni and Shi http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Fu, Yibao
Jia, Jinmeng
Yue, Lishu
Yang, Ruiying
Guo, Yongli
Ni, Xin
Shi, Tieliu
Systematically Analyzing the Pathogenic Variations for Acute Intermittent Porphyria
title Systematically Analyzing the Pathogenic Variations for Acute Intermittent Porphyria
title_full Systematically Analyzing the Pathogenic Variations for Acute Intermittent Porphyria
title_fullStr Systematically Analyzing the Pathogenic Variations for Acute Intermittent Porphyria
title_full_unstemmed Systematically Analyzing the Pathogenic Variations for Acute Intermittent Porphyria
title_short Systematically Analyzing the Pathogenic Variations for Acute Intermittent Porphyria
title_sort systematically analyzing the pathogenic variations for acute intermittent porphyria
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753391/
https://www.ncbi.nlm.nih.gov/pubmed/31572191
http://dx.doi.org/10.3389/fphar.2019.01018
work_keys_str_mv AT fuyibao systematicallyanalyzingthepathogenicvariationsforacuteintermittentporphyria
AT jiajinmeng systematicallyanalyzingthepathogenicvariationsforacuteintermittentporphyria
AT yuelishu systematicallyanalyzingthepathogenicvariationsforacuteintermittentporphyria
AT yangruiying systematicallyanalyzingthepathogenicvariationsforacuteintermittentporphyria
AT guoyongli systematicallyanalyzingthepathogenicvariationsforacuteintermittentporphyria
AT nixin systematicallyanalyzingthepathogenicvariationsforacuteintermittentporphyria
AT shitieliu systematicallyanalyzingthepathogenicvariationsforacuteintermittentporphyria